397 related articles for article (PubMed ID: 29034105)
1. Changes of the Intestinal Microbiome-Host Homeostasis in HIV-Infected Individuals - A Focus on the Bacterial Gut Microbiome.
Ribeiro ABDTM; Heimesaat MM; Bereswill S
Eur J Microbiol Immunol (Bp); 2017 Sep; 7(3):158-167. PubMed ID: 29034105
[TBL] [Abstract][Full Text] [Related]
2. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
[TBL] [Abstract][Full Text] [Related]
3. Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.
Bandera A; De Benedetto I; Bozzi G; Gori A
Curr Opin HIV AIDS; 2018 Jan; 13(1):73-80. PubMed ID: 29045252
[TBL] [Abstract][Full Text] [Related]
4. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the Microbiota to Intestinal Homeostasis and its Role in the Pathogenesis of HIV-1 Infection.
Luján JA; Rugeles MT; Taborda NA
Curr HIV Res; 2019; 17(1):13-25. PubMed ID: 30854974
[TBL] [Abstract][Full Text] [Related]
6. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
Villar-García J; Güerri-Fernández R; Moya A; González A; Hernández JJ; Lerma E; Guelar A; Sorli L; Horcajada JP; Artacho A; D Auria G; Knobel H
PLoS One; 2017; 12(4):e0173802. PubMed ID: 28388647
[TBL] [Abstract][Full Text] [Related]
7. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
8. The gut microbiome and HIV-1 pathogenesis: a two-way street.
Dillon SM; Frank DN; Wilson CC
AIDS; 2016 Nov; 30(18):2737-2751. PubMed ID: 27755100
[TBL] [Abstract][Full Text] [Related]
9. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials.
Kim CJ; Walmsley SL; Raboud JM; Kovacs C; Coburn B; Rousseau R; Reinhard R; Rosenes R; Kaul R
HIV Clin Trials; 2016 Jul; 17(4):147-57. PubMed ID: 27267710
[TBL] [Abstract][Full Text] [Related]
10. The possible mechanisms of the human microbiome in allergic diseases.
Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
[TBL] [Abstract][Full Text] [Related]
11. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
Peterson CT; Sharma V; Elmén L; Peterson SN
Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
[TBL] [Abstract][Full Text] [Related]
12. Interaction between the gut microbiome and mucosal immune system.
Shi N; Li N; Duan X; Niu H
Mil Med Res; 2017; 4():14. PubMed ID: 28465831
[TBL] [Abstract][Full Text] [Related]
13. Microbiota and Probiotics in Health and HIV Infection.
D'Angelo C; Reale M; Costantini E
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28621726
[TBL] [Abstract][Full Text] [Related]
14. Systems Analysis of Gut Microbiome Influence on Metabolic Disease in HIV-Positive and High-Risk Populations.
Armstrong AJS; Quinn K; Fouquier J; Li SX; Schneider JM; Nusbacher NM; Doenges KA; Fiorillo S; Marden TJ; Higgins J; Reisdorph N; Campbell TB; Palmer BE; Lozupone CA
mSystems; 2021 May; 6(3):. PubMed ID: 34006628
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota diversity predicts immune status in HIV-1 infection.
Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svärd J; Rudi K; Sönnerborg A
AIDS; 2015 Nov; 29(18):2409-18. PubMed ID: 26355675
[TBL] [Abstract][Full Text] [Related]
16. HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation.
Gootenberg DB; Paer JM; Luevano JM; Kwon DS
Curr Opin Infect Dis; 2017 Feb; 30(1):31-43. PubMed ID: 27922852
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
[TBL] [Abstract][Full Text] [Related]
18. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism.
Vujkovic-Cvijin I; Dunham RM; Iwai S; Maher MC; Albright RG; Broadhurst MJ; Hernandez RD; Lederman MM; Huang Y; Somsouk M; Deeks SG; Hunt PW; Lynch SV; McCune JM
Sci Transl Med; 2013 Jul; 5(193):193ra91. PubMed ID: 23843452
[TBL] [Abstract][Full Text] [Related]
19. Th17 cells, HIV and the gut mucosal barrier.
Dandekar S; George MD; Bäumler AJ
Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the oral microbiome in HIV infection: causes, effects and potential interventions.
Li S; Su B; He QS; Wu H; Zhang T
Chin Med J (Engl); 2021 Oct; 134(23):2788-2798. PubMed ID: 34670249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
